Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Alirocumab 10mg | 10mg
SDP

Catalog No. 5000322128
Encompass_Preferred

Alirocumab is an anti-PCSK9 human monoclonal antibody Alirocumab inhibits PCSK9 Alirocumab reduces NLRP3 inflammasome regulates Nrf2/HO-1 HMGB1/NF- B and Fractalkine/CX3CR1 Alirocumab increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood Alirocumab improves atherosclerosis and inflammation[1][2][3][4][5][6][7][8][9][10][11]

Catalog No. 50-003-22128 Supplier Medchemexpress LLC Supplier No. HYP992810MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Alirocumab is an anti-PCSK9 human monoclonal antibody Alirocumab inhibits PCSK9 Alirocumab reduces NLRP3 inflammasome regulates Nrf2/HO-1 HMGB1/NF- B and Fractalkine/CX3CR1 Alirocumab increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood Alirocumab improves atherosclerosis and inflammation[1][2][3][4][5][6][7][8][9][10][11]

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.